Finance

Lists
Why is SPARC down 3.22%?
Dive Deeper
SPARC:NSE
Sun Pharma Advanced Research Co Ltd
₹173.50
-3.22%
(-5.77) 1D
Oct 22, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for SPARC...
Open
₹178.00
High
₹178.00
Low
₹171.82
Mkt. cap
56.30B
Avg. vol.
927.23K
Volume
663.76K
P/E ratio
3.55
52-wk high
₹289.00
52-wk low
₹108.00
EPS
₹48.91
Shares outstanding
255.99M
No. of employees
279
Open
₹178.00
High
₹178.00
Low
₹171.82
Mkt. cap
56.30B
Avg. vol.
927.23K
Volume
663.76K
P/E ratio
3.55
52-wk high
₹289.00
52-wk low
₹108.00
EPS
₹48.91
Shares outstanding
255.99M
No. of employees
279
News stories
From web sources and news partners
About Sun Pharma Advanced Research Co Ltd
CEO-
Employees279
Founded2006
Headquarters-
SectorPharmaceutical industry
Websitesparc.life
Last report
Aug 10, 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
399.20M / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
78.60M
84.50M
18.53B
399.20M
Cost of goods sold
61.00M
72.10M
115.06M
76.60M
Cost of revenue
61.00M
72.10M
115.06M
76.60M
Research and development expenses
80.10M
62.70M
28.44M
132.60M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
483.40M
424.60M
557.37M
448.00M
Operating expense
700.40M
604.50M
605.33M
684.60M
Total operating expenses
761.40M
676.60M
720.39M
761.20M
Operating income
-682.80M
-592.10M
17.81B
-362.00M
Other non operating income
100.00K
-
-116.03M
236.60M
EBT including unusual items
-757.90M
-803.50M
17.61B
-206.70M
EBT excluding unusual items
-757.90M
-679.90M
17.61B
-206.70M
Income tax expense
600.00K
700.00K
-3.84M
1.10M
Effective tax rate
-0.08%
-0.09%
-0.02%
-0.53%
Other operating expenses
111.30M
91.50M
-3.44M
82.00M
Net income
-758.50M
-804.20M
17.61B
-207.80M
Net profit margin
-965.01%
-951.72%
95.04%
-52.05%
Earnings per share
-
-
-
-
Interest and investment income
-
-
102.87M
-
Interest expense
-75.20M
-87.80M
-90.07M
-81.30M
Net interest expenses
-75.20M
-87.80M
12.80M
-81.30M
Depreciation and amortization charges
25.60M
25.70M
22.96M
22.00M
EBITDA
-656.60M
-570.75M
17.83B
-342.34M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps